SARS-CoV-2 Envelope Antikörper (C-Term)
Kurzübersicht für SARS-CoV-2 Envelope Antikörper (C-Term) (ABIN7273009)
Target
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Verwendungszweck
- anti-Envelope Protein (SARS-CoV-2)
-
Sequenz
- MNIVNVSLVK PSFYVYSRVK NLNSSRVPDL LV
-
Spezifität
- In lysates of transfected cells with the plasmid containing the sequence used, detects the fusion protein by Western blot.
-
Kreuzreaktivität (Details)
- Reacts with SARS-CoV-2 protein
-
Aufreinigung
- Epitope affinity purified
-
Immunogen
- Affinity purified recombinant fusion protein using the C-terminal of Envelope protein (residues 45 to stop) and produced in E. coli.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB:1:500-1:2,000
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- 3 mg/mL
-
Buffer
- PBS, 20 % glycerol and 0.05 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- The antibody solution should be gently mixed before use.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- For continuous use, store at 2-8 C for one-two days. For extended storage, store in -20 C freezer. Working dilution samples should be discarded if not used within 12 hours.
-
-
- SARS-CoV-2 Envelope (SARS-CoV-2 E)
-
Andere Bezeichnung
- Envelope Protein (SARS-CoV-2)
-
Substanzklasse
- Viral Protein
-
Hintergrund
-
Envelope (E) is one of the structural proteins of the virus. This protein is a small polypeptide that contains at least one α-helical transmembrane domain and it involved in life cycle of SARS-CoV-2, such as assembly, budding, envelope formation.
ORF4, E SARS Coronavirus-2 antibody.
Target
-